All updates
All updates
today 47The Lancet评分1919 文献与产业新闻评分1818 STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
文献与产业新闻评分1414 Clinical trials reach a new automation inflection point
文献与产业新闻评分2323 Pennsylvania officials report state’s third death involving measles
顶刊论文（社媒热度）评分2121 Idiopathic Normal Pressure Hydrocephalus: A Review.
文献与产业新闻评分1818 Opinion: Restoring public trust in science doesn’t have a simple solution. That’s OK
文献与产业新闻评分1111 Opinion: Am I a hypocrite for loving football despite CTE?
顶刊论文（社媒热度）评分2323 Rethinking the global health system for a new international order.
文献与产业新闻评分2222 Rethinking the global health system for a new international order
文献与产业新闻评分2525 Rethinking the immune recognition of cell walls in human fungal pathogens: Mechanisms, controversies and translational significance
文献与产业新闻评分1616 Prospective evidence for conversational medical AI is hard, but non-negotiable
The Lancet精选评分2525 [Articles] Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study
The Lancet评分2323 [Comment] The US experiments with international reference pricing for prescription drugs
文献与产业新闻评分2020 A multimodal murmuration for immunotherapy
中文产业新闻Chinese source评分1818 桑威教授：深耕CD30靶点细胞治疗，探索CAR-T序贯移植诊疗新路径
文献与产业新闻评分2121 Experimental evidence for the beneficial effects of low-concentration ozone
文献与产业新闻评分2222 Hypoxia-responsive supramolecular systems based on macrocycles and self-assembly structures
文献与产业新闻评分2424 Hydrogen sulfide-releasing hydrogels: a new perspective on clinical translation
顶刊论文（社媒热度）评分2929 From reading to writing.
文献与产业新闻评分1818 Letter from the Editor: FIH data — is now the time for change?
顶刊论文（社媒热度）评分3535 Startups mine 'dark proteome' for new drug targets.
文献与产业新闻评分1717 Beyond clinical endpoints: Rethinking ALS drug development through disease biology
文献与产业新闻评分2525 The future of RAS inhibitors
文献与产业新闻评分3131 STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
文献与产业新闻评分1414 Opinion: I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over
文献与产业新闻评分1313 Opinion: I’m a public health communications consultant. Pro-vaccine advocacy needs more fun
顶刊论文（社媒热度）评分2020 Our Future Health and the next generation of population medicine.
文献与产业新闻评分1717 In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy
文献与产业新闻评分1212 Scientists boycott American Diabetes Association as fallout of June conference fracas escalates
文献与产业新闻评分1818 Why two promising heart drugs flopped and what’s next
文献与产业新闻评分1010 The signal that changes everything: understanding MRD in oncology drug development
文献与产业新闻评分1717 STAT+: The gifts from pharma companies that keep on giving
文献与产业新闻评分1616 STAT+: Can AI save rural health care?
文献与产业新闻评分1313 Why Earlier Commercial Involvement Drives Smarter Strategy
文献与产业新闻评分1111 Biopharma’s next data advantage may start with genetics
文献与产业新闻评分1919 Novartis’ growth drivers, beyond the setbacks
顶刊论文（社媒热度）评分1616 Rheumatoid Arthritis in Adults: A Review.
文献与产业新闻评分1717 Oz says ‘AI-based avatars’ can help rural communities. Some leaders disagree
顶刊论文（社媒热度）评分1717 The Value Cube: translating clinical benefit into realizable value in global oncology.
文献与产业新闻评分1818 STAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon